Noxopharm: Announces novel mRNA “vaccine enhancer” product
Noxopharm Announces novel mRNA “vaccine enhancer” productNoxopharm (NOX) is developing a new mRNA “vaccine enhancer” product to improve the effectiveness of vaccines and...
Noxopharm: Appoints new CEO
Noxopharm Appoints new CEONoxopharm Limited (NOX) announces a shift in leadership in preparation for an upcoming ‘growth phase’
Dr Gisela Mautner has been...
Noxopharm: Signs licensing agreement with Hudson Institute for RNA technology
Noxopharm Signs licensing agreement with Hudson Institute for RNA technologyNoxopharm (NOX) signs licensing agreement with Hudson Institute of Medical Research for its cutting-edge...

